Companies: 10,795·Total market cap: $144.5T
Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc.

LRMRNASDAQHealthcare● Active
$3.08
$-0.09(-2.72%)
Market Cap$263914155
P/E Ratio—
52W High$6.42
52W Low$2.22
ForecastMarket CapPE Ratio

Larimar Therapeutics, Inc.（LRMR）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

lrmr · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

SellBuy

Buy

8 位分析师

共识

评级分布

Strong Buy
0
Buy
8
Hold
0
Sell
0
Strong Sell
0
合计: 8 · 买入占比: 100.0%

12 个月目标价

High

$12.00

Consensus

$12.00

+287.8% upside

Low

$12.00

Median: $12 · Last Close: $3.09

Larimar Therapeutics, Inc.（LRMR）的分析师共识为 Buy，基于过去 3 个月内 8 位华尔街分析师的评级。LRMR 的 12 个月平均目标价为 $12.00，相对当前价 $3.09 代表 +287.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$2.94↓ 5.00%

1-day model range: $2.91–$2.97. Peak: $2.97 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%36%64%
0Buy
5Neutral
9Sell
RSI (14)43.9Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · LRMR · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$3.21SELL
MA 10$3.35SELL
MA 20$3.52SELL
MA 50$4.14SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $LRMR · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.22SELL
EMA 10$3.32SELL
EMA 20$3.53SELL
EMA 50$4.03SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $LRMR · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Wedbush2026-05-18
Maintains
Outperform→Outperform
Wedbush2026-03-20
Maintains
Outperform→Outperform
Wedbush2026-03-03
Maintains
Outperform→Outperform
Citigroup2026-02-25
Maintains
Buy→Buy
Wedbush2026-02-25
Maintains
Outperform→Outperform
Oppenheimer2025-10-02
Maintains
Outperform→Outperform
Baird2025-09-30
Maintains
Outperform→Outperform
Wedbush2025-09-30
Maintains
Outperform→Outperform
JMP Securities2025-08-19
Maintains
Market Outperform→Market Outperform
JMP Securities2025-08-15
Maintains
Market Outperform→Market Outperform

Wall Street analysts have recently issued updated ratings on Larimar Therapeutics, Inc. (LRMR) stock. Of the recent 47 rating actions, 2 were upgrades and 1 were downgrades. 8 analysts currently cover LRMR.

分析师推荐趋势

Buy ratings2 → 1↓ 1
Hold ratings0 → 0
Sell ratings0 → 0

LRMR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$2M

↓ 98.5% YoY

Revenue Next Year

$58M

↑ 2416.4% YoY

EPS This Year

$-1.66

EPS Next Year

$-1.26

↓ 24.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LRMR EPS of $-1.66 for the current fiscal year, based on estimates from 6 analysts. The LRMR revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LRMR 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LRMR 的共识目标价为 $12.00（+287.8% 上行空间），分析师共识为 Buy。

LRMR 的短期预测（明日）为 $2.94（-5.00%）。

Larimar Therapeutics, Inc. 在 NASDAQ 上市，代码 LRMR。LRMR 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

LRMR 预测 · 8 个问题

根据 8 位华尔街分析师，LRMR 的 12 个月平均目标价为 $12.00，最高 $12.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $3.09，隐含约 +287.8% 的上行空间。

LRMR 目标价LRMR 分析师目标价LRMR 12个月目标价目标价 LRMR

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.